Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
Objective: to assess the clinical and economic efficiency and impact on the budget when using the drug Mirabegron in the treatment of an overactive bladder. Materials and methods. Study design - retrospective analysis of published data. Pharmacoeconomic analysis methods - cost analysis, clinical and...
Saved in:
Main Authors: | I. N. Dyakov (Author), G. R. Kasyan (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022) -
Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022) -
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
by: Shaw C, et al.
Published: (2023) -
Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017) -
Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
by: Luisa Gracio Ferreira Sartori, et al.
Published: (2023)